Cargando…

Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals’ Quality of Life and the Sustainability of Health-care Systems

Detalles Bibliográficos
Autores principales:	Bousfiha, Ahmed Aziz, Duff, Carla, Hsieh, Elena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610678/ https://www.ncbi.nlm.nih.gov/pubmed/28974952 http://dx.doi.org/10.3389/fimmu.2017.01165

Ejemplares similares

Primary Immunodeficiencies: A Decade of Progress and a Promising Future
por: Meyts, Isabelle, et al.
Publicado: (2021)

Cytokine dysregulation despite immunoglobulin replacement therapy in common variable immunodeficiency (CVID)
por: Poto, Remo, et al.
Publicado: (2023)

Neonatal sepsis and transient immunodeficiency: Potential for novel immunoglobulin therapies?
por: Beudeker, Coco R., et al.
Publicado: (2022)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
por: Perez, Elena E., et al.
Publicado: (2021)

Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
por: Al-Herz, Waleed, et al.
Publicado: (2011)

Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
por: Al-Herz, Waleed, et al.
Publicado: (2014)

Recurrent and Sustained Viral Infections in Primary Immunodeficiencies
por: Ruffner, Melanie A., et al.
Publicado: (2017)

Corrigendum: Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency
por: Al-Herz, Waleed, et al.
Publicado: (2014)

Serum Free Immunoglobulins Light Chains: A Common Feature of Common Variable Immunodeficiency?
por: Guevara-Hoyer, Kissy, et al.
Publicado: (2020)

Fatigue Is Common in Immunoglobulin G Subclass Deficiency and Correlates With Inflammatory Response and Need for Immunoglobulin Replacement Therapy
por: Wågström, Per, et al.
Publicado: (2022)

What Is the Burden of Immunoglobulin Replacement Therapy in Adult Patients With Primary Immunodeficiencies? A Systematic Review
por: Jones, Georgina L., et al.
Publicado: (2018)

Ensuring practical feasibility and sustainability of research work: Need of the hour
por: Bajwa, Sukhminder Jit Singh, et al.
Publicado: (2020)

Current Perspectives and Unmet Needs of Primary Immunodeficiency Care in Asia Pacific
por: Leung, Daniel, et al.
Publicado: (2020)

Intellectual property rights need to be subverted to ensure global vaccine access
por: Sariola, Salla
Publicado: (2021)

Ensuring access to justice: the need for community paralegals to end AIDS by 2030
por: Hinman, Kati, et al.
Publicado: (2023)

Changing the Lives of People With Primary Immunodeficiencies (PI) With Early Testing and Diagnosis
por: Condino-Neto, Antonio, et al.
Publicado: (2018)

Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies
por: Kobayashi, Roger H., et al.
Publicado: (2019)

The business management training needs of South African Biokineticists to ensure business sustainability
por: Lumb, MJ, et al.
Publicado: (2021)

Facilitated Subcutaneous Immunoglobulin Replacement Therapy in Clinical Practice: A Two Center, Long-Term Retrospective Observation in Adults With Primary Immunodeficiencies
por: Wiesik-Szewczyk, Ewa, et al.
Publicado: (2020)

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig(®)]) in the treatment of patients with primary immunodeficiencies
por: Kobayashi, Roger H., et al.
Publicado: (2022)

Ensuring Viral Safety of Equine Immunoglobulins during Production
por: Mashin, V. V., et al.
Publicado: (2022)

Ensuring accurate testing for human immunodeficiency virus in Myanmar
por: Kyaw, Latt Latt, et al.
Publicado: (2015)

Epigenetic Regulation of Individual Modules of the immunoglobulin heavy chain locus 3′ Regulatory Region
por: Birshtein, Barbara K.
Publicado: (2014)

Strategic considerations on developing a CHIKV vaccine and ensuring equitable access for countries in need
por: Cherian, Neil, et al.
Publicado: (2023)

Low rates of headache and migraine associated with intravenous immunoglobulin infusion using a 15-minute rate escalation protocol in 123 patients with primary immunodeficiency
por: Geng, Bob, et al.
Publicado: (2023)

Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection
por: MacDuff, Donna A, et al.
Publicado: (2015)

10.B. Workshop: Combatting AMR: European collaboration to ensure sustained access to effective antibiotics
Publicado: (2023)

Cellular and humoral immunogenicity of the COVID-19 vaccine and COVID-19 disease severity in individuals with immunodeficiency
por: Murray, C. E., et al.
Publicado: (2023)

How to Ensure Fiscal Sustainability in Russia
por: Sokolov, I. A., et al.
Publicado: (2021)

Cataract services: ensuring access for everyone
por: Lindfield, Robert
Publicado: (2014)

Ensuring Equitable Access to School Meals
por: Fleischhacker, Sheila, et al.
Publicado: (2020)

Vaccine manufacturing is essential to ensure access
por: Palomares, Laura A.
Publicado: (2022)

Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks
por: Kurtović, Tihana, et al.
Publicado: (2022)

Proximity of Cytomegalovirus-Specific CD8(+) T Cells to Replicative Senescence in Human Immunodeficiency Virus-Infected Individuals
por: Heath, John Joseph, et al.
Publicado: (2018)

Prolonged Excretion of Poliovirus among Individuals with Primary Immunodeficiency Disorder: An Analysis of the World Health Organization Registry
por: Macklin, Grace, et al.
Publicado: (2017)

Strategies for B-Cell Receptor Repertoire Analysis in Primary Immunodeficiencies: From Severe Combined Immunodeficiency to Common Variable Immunodeficiency
por: IJspeert, Hanna, et al.
Publicado: (2015)

Analyzing Immunoglobulin Repertoires
por: Chaudhary, Neha, et al.
Publicado: (2018)

Circulating Plasmablasts from Chronically Human Immunodeficiency Virus-Infected Individuals Predominantly Produce Polyreactive/Autoreactive Antibodies
por: Liao, Hongyan, et al.
Publicado: (2017)

Recombinant Human C1 Esterase Inhibitor for the Management of Adverse Events Related to Intravenous Immunoglobulin Infusion in Patients With Common Variable Immunodeficiency or Polyneuropathy: A Pilot Open-Label Study
por: Melamed, Isaac R., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e8km4nqas6t148r8rlafdq56pp